Cargando…
Efficacy and Safety of Niaoduqing Particles for Delaying Moderate-to-severe Renal Dysfunction: A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Study
BACKGROUND: Chronic kidney disease (CKD) with moderate-to-severe renal dysfunction usually exhibits an irreversible course, and available treatments for delaying the progression to end-stage renal disease are limited. This study aimed to assess the efficacy and safety of the traditional Chinese medi...
Autores principales: | Zheng, Ying, Cai, Guang-Yan, He, Li-Qun, Lin, Hong-Li, Cheng, Xiao-Hong, Wang, Nian-Song, Jian, Gui-Hua, Liu, Xu-Sheng, Liu, Yu-Ning, Ni, Zhao-Hui, Fang, Jing-Ai, Ding, Han-Lu, Guo, Wang, He, Ya-Ni, Wang, Li-Hua, Wang, Ya-Ping, Yang, Hong-Tao, Ye, Zhi-Ming, Yu, Ren-Huan, Zhao, Li-Juan, Zhou, Wen-Hua, Li, Wen-Ge, Mao, Hui-Juan, Zhan, Yong-Li, Hu, Zhao, Yao, Chen, Wei, Ri-Bao, Chen, Xiang-Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5684630/ https://www.ncbi.nlm.nih.gov/pubmed/29052559 http://dx.doi.org/10.4103/0366-6999.216407 |
Ejemplares similares
-
NiaoDuQing granules relieve chronic kidney disease symptoms by decreasing renal fibrosis and anemia
por: Wang, Xu, et al.
Publicado: (2017) -
The efficacy and safety of Niaoduqing granules in the treatment of diabetic kidney disease: a systematic review and meta-analysis
por: Song, Chaoqun, et al.
Publicado: (2023) -
Effects of Niaoduqing granules on inflammatory response of diabetic kidney disease: A meta‑analysis
por: Zhou, Peipei, et al.
Publicado: (2023) -
Basigin-2 is the predominant basigin isoform that promotes tumor cell migration and invasion and correlates with poor prognosis in epithelial ovarian cancer
por: Zhao, Shu-Hua, et al.
Publicado: (2013) -
Oral PSORI-CM01, a Chinese herbal formula, plus topical sequential therapy for moderate-to-severe psoriasis vulgaris: pilot study for a double-blind, randomized, placebo-controlled trial
por: Yao, Dan-Ni, et al.
Publicado: (2016)